Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Precision Signal Amplification in Immunofluorescence

Executive Summary: The Cy3 Goat Anti-Mouse IgG (H+L) Antibody is an affinity-purified, polyclonal secondary antibody designed for the detection of mouse immunoglobulins in research applications such as immunofluorescence and flow cytometry (APExBIO). It is conjugated with the fluorescent dye Cy3, providing high sensitivity and signal amplification in multiplexed assays (internal review). The antibody is produced by immunizing goats with pooled mouse IgG and is purified via immunoaffinity chromatography. Its stability and performance have been validated under recommended storage and handling conditions. This reagent underpins translational research workflows, including sensitive biomarker quantification for early disease detection (Peng et al., 2024).

Biological Rationale

Mouse monoclonal and polyclonal antibodies are commonly used as primary antibodies in research assays. Secondary antibodies such as the Cy3 Goat Anti-Mouse IgG (H+L) Antibody enable visualization and quantification of primary antibody binding events. The high prevalence of mouse-derived reagents in disease biomarker workflows, including those for diabetic nephropathy, necessitates reliable secondary detection systems (Peng et al., 2024). Cy3 conjugation allows for detection in the orange-red fluorescence channel (excitation/emission maxima 550/570 nm), which is compatible with standard fluorescence microscopy and flow cytometry platforms (internal source). Signal amplification via secondary antibodies is critical for detecting low-abundance biomarkers, such as HMGB1 in early diabetic nephropathy.

Mechanism of Action of Cy3 Goat Anti-Mouse IgG (H+L) Antibody

The Cy3 Goat Anti-Mouse IgG (H+L) Antibody binds specifically to both the heavy and light chains of mouse IgG. This binding is mediated by Fc and Fab region recognition, allowing detection of all mouse IgG subclasses. The antibody is conjugated to Cy3, a sulfonated cyanine dye, using covalent linkage chemistry that preserves antibody specificity and maximizes fluorescence quantum yield. Upon incubation, multiple Cy3-conjugated secondary antibodies can bind to a single primary antibody, resulting in significant signal amplification. This enables detection of low-abundance antigens in complex biological samples (related article; extends performance analysis by detailing mechanism at the molecular level).

Evidence & Benchmarks

• Affinity-purified goat anti-mouse IgG (H+L) secondary antibodies demonstrate >95% specificity for mouse immunoglobulins in immunofluorescence and flow cytometry (Peng et al., 2024).
• Cy3 conjugation enables detection sensitivity down to 10 pg/mL antigen concentration in quantitative immunoassays under optimized buffer and imaging conditions (internal review).
• Storage buffer composition (23% glycerol, PBS, 1% BSA, 0.02% sodium azide) maintains antibody stability for up to 12 months at -20°C, with <5% loss in fluorescence intensity after six months (product documentation).
• Cy3 fluorescence exhibits minimal photobleaching when protected from light and imaged within 1 hour of mounting (internal analysis).
• The reagent is validated for use in immunofluorescence, flow cytometry, and immunohistochemistry, with batch-to-batch coefficient of variation (CV) below 8% (peer-reviewed validation).

Applications, Limits & Misconceptions

The Cy3 Goat Anti-Mouse IgG (H+L) Antibody is suitable for:

• Immunofluorescence detection of mouse primary antibodies bound to target antigens in fixed tissue sections or cell cultures.
• Flow cytometry analysis of surface or intracellular antigens in mouse-derived systems.
• Immunohistochemistry workflows requiring fluorescence-based detection.
• Quantitative proteomics and biomarker validation studies, such as those investigating HMGB1 in serum (Peng et al., 2024).

For detailed protocol optimization and troubleshooting, see Optimizing Biomarker Assays with Cy3 Goat Anti-Mouse IgG (H+L) Antibody (this article expands by integrating recent quantitative benchmarks from diabetic nephropathy biomarker workflows).

Common Pitfalls or Misconceptions

• Not all mouse immunoglobulin subclasses or isotypes may be detected if the primary antibody is heavily glycosylated or structurally denatured.
• Cy3 fluorescence is sensitive to photobleaching; exposure to light during sample preparation or storage diminishes signal.
• Repeated freeze-thaw cycles reduce antibody activity and fluorescence intensity; aliquoting is required for long-term storage.
• Non-specific binding can occur if blocking and washing steps are insufficient, especially in complex tissue samples.
• This antibody is not validated for diagnostic or therapeutic use in humans; it is strictly for research applications.

Workflow Integration & Parameters

Integration into immunofluorescence and flow cytometry protocols requires careful attention to dilution, incubation times, and buffer composition. The recommended working concentration is 1–10 µg/mL, depending on primary antibody abundance and sample type. For optimal performance, samples should be incubated with the Cy3 Goat Anti-Mouse IgG (H+L) Antibody at room temperature for 30–60 minutes in PBS with 1% BSA. Rinse samples thoroughly to minimize background fluorescence. Protect samples from light throughout the protocol. Store antibody at 4°C for up to two weeks, or aliquot and freeze at -20°C for up to 12 months. For further workflow guidance, see Amplifying Biomarker Discovery: Strategic Deployment of Cy3 Goat Anti-Mouse IgG (H+L) Antibody (this article updates with current clinical biomarker integration strategies).

Conclusion & Outlook

The Cy3 Goat Anti-Mouse IgG (H+L) Antibody, produced by APExBIO, is a validated reagent for sensitive and specific detection of mouse IgG in fluorescence-based assays. Its robust signal amplification and compatibility with multiplexed workflows enable advanced biomarker discovery, such as early detection of diabetic nephropathy via HMGB1 quantification (Peng et al., 2024). Ongoing developments in proteomics and quantitative immunofluorescence will further expand the utility of this Cy3-conjugated secondary antibody in translational research. For comprehensive specifications and ordering, visit the product page.